105 related articles for article (PubMed ID: 6530707)
1. Routine gynaecological clinic in northern Ghana.
Elkins TE; Honbarrier J; Zachharian M; Coleman SA; Sweeney PJ
J Trop Med Hyg; 1984 Oct; 87(5):193-6. PubMed ID: 6530707
[TBL] [Abstract][Full Text] [Related]
2. The natural history of Pap test screening in a rural population.
Rosenfeld JA
Tenn Med; 1998 May; 91(5):179-82. PubMed ID: 9584605
[No Abstract] [Full Text] [Related]
3. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
Sankaranarayanan R; Budukh AM; Rajkumar R
Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
[TBL] [Abstract][Full Text] [Related]
4. Opportunistic cervical screening at a sexual health clinic.
Treacy A; Lyons F; Mulcahy F
Ir Med J; 2006; 99(7):198-9. PubMed ID: 16986561
[TBL] [Abstract][Full Text] [Related]
5. Cytologically diagnosed Gardnerella vaginalis infection and cervical (pre)neoplasia as established in population-based cervical screening.
Klomp JM; Boon ME; Van Haaften M; Heintz AP
Am J Obstet Gynecol; 2008 Nov; 199(5):480.e1-5. PubMed ID: 18565490
[TBL] [Abstract][Full Text] [Related]
6. [Role of examination offices in preventing genital cancer in women of retirement age].
Alekhnovich MV
Vopr Onkol; 1974; 20(9):103-6. PubMed ID: 4279497
[No Abstract] [Full Text] [Related]
7. Pap smear screening and invasive cervical cancer.
Brown RK; Barker WH
J Fam Pract; 1982 Nov; 15(5):875-9. PubMed ID: 7130915
[TBL] [Abstract][Full Text] [Related]
8. [Pollen granules and other plant findings in cervico-vaginal smears].
Accorsi CA; Aisoni ML; Bandini Mazzanti M; Forlani L; Rivasi F
Quad Sclavo Diagn; 1981 Sep; 17(3):342-55. PubMed ID: 7343987
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of the validity of vaginal-cervical cytologic examination in 162 pre- and post-menopausal patients].
Martelli M; Rapezzi R; Roncone L; Davì E; Mancini L
Minerva Ginecol; 1996 Jun; 48(6):235-8. PubMed ID: 8927283
[TBL] [Abstract][Full Text] [Related]
10. Analysis of 1000 colposcopies performed in a Nicaraguan clinic. Comparison with results of 2000 colposcopies performed in a Brazilian hospital.
Guido C; Cuadra G
Int Surg; 1974 Sep; 59(9):475-7. PubMed ID: 4412017
[No Abstract] [Full Text] [Related]
11. [Colpocytohistological correlations of lesions of the uterine portio extending to the fornix vaginae].
Volante E; Devalle G; Lerro R
Minerva Ginecol; 1981 Apr; 33(4):337-40. PubMed ID: 7243076
[No Abstract] [Full Text] [Related]
12. Downstaging of cervical cancer.
Ananth R
J Indian Med Assoc; 2000 Feb; 98(2):41-4. PubMed ID: 11016148
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
14. [Experience with prophylactic examinations of rural women for the detection of malignant neoplasms (based on data from the northern group of districts of the Udmurt ASSR)].
Iasakova AA; Semakin IuF; Kuchurin EA
Vopr Onkol; 1975; 21(3):81-4. PubMed ID: 124112
[TBL] [Abstract][Full Text] [Related]
15. The value and dangers of gynaecological cytology.
Fry R; Linder AM; Bull MM; Brinton A
S Afr Med J; 1976 Jan; 50(2):35-8. PubMed ID: 1251273
[TBL] [Abstract][Full Text] [Related]
16. The Fitzroy Valley Pap Smear Register. Cervical screening in a population of Australian aboriginal women.
Mak DB; Straton JA
Med J Aust; 1993 Feb; 158(3):163-6. PubMed ID: 8450781
[TBL] [Abstract][Full Text] [Related]
17. [Status of screening tests for cervical cancer and its precancerous lesion].
Zhao FH; Rong SD; Qiao YL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):638-41. PubMed ID: 12901114
[TBL] [Abstract][Full Text] [Related]
18. [The activity of the social medical center for tumor prevention diagnosis and therapy. I. Cytology].
Guastalla L; Doria-Miglietta F
Pathologica; 1967; 59(877):325-8. PubMed ID: 5620177
[No Abstract] [Full Text] [Related]
19. Comparing women's reports with medical diagnoses of reproductive morbidity conditions in rural Egypt.
Zurayk H; Khattab H; Younis N; Kamal O; el-Helw M
Stud Fam Plann; 1995; 26(1):14-21. PubMed ID: 7785064
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
